GSA CAPITAL PARTNERS LLP - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 83 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$314,000
+19.4%
559,489
-16.0%
0.03%
+6.7%
Q4 2018$263,000
+436.7%
665,776
+2869.2%
0.03%
+1400.0%
Q2 2018$49,00022,4230.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 2,595,484$5,710,0004.85%
Cypress Capital Management LLC (WY) 321,725$708,0000.74%
Noven Financial Group, Inc. 103,964$229,0000.12%
Transform Wealth, LLC 205,481$452,0000.08%
Cutter & CO Brokerage, Inc. 50,000$110,0000.04%
TRUSTCORE FINANCIAL SERVICES, LLC 44,500$98,0000.04%
GHP Investment Advisors, Inc. 100,000$220,0000.03%
BRIGHTON JONES LLC 85,555$188,0000.02%
Valeo Financial Advisors, LLC 330,000$155,0000.02%
TRUSTCORE FINANCIAL SERVICES, LLC 27,348$60,0000.02%
View complete list of AMPIO PHARMACEUTICALS INC shareholders